Stephan Foster, PharmD, FAPhA, FNAP

Articles by Stephan Foster, PharmD, FAPhA, FNAP

Influenza Case 2: Male Patient With Chronic Health Conditions

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Influenza Case 1: Female Patient With Asthma and Egg Allergy

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Vaccination Misconceptions and Educating Patients

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Influenza Vaccination Timing and Reluctance

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Pros and Cons of Available Influenza Vaccines

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Identifying Patients at High Risk for Influenza Complications

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Addressing Influenza in the COVID-19 Era

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

A group of experts led by Tina Q. Tan, MD, FAAP, FIDSA, FDIPS, discuss how best to address influenza prevention, identification, and treatment in the COVID-19 era and beyond.

Similarities and Differences in COVID-19 and Influenza

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Feasibility of Concurrent COVID-19 and Influenza Vaccination

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

The Impact of Distancing, Masks, and Vaccination on Influenza

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Evolving Influenza Trends Throughout COVID-19 Pandemic

ByTina Q. Tan, M.D., FAAP, FIDSA, FDIPS,John J Russell, MD, FAAFP,Stephan Foster, PharmD, FAPhA, FNAP,Charles Vega, MD

October 12th 2021

Latest Updated Articles

Feasibility of Concurrent COVID-19 and Influenza Vaccination
October 12th 2021
Similarities and Differences in COVID-19 and Influenza
October 12th 2021
Evolving Influenza Trends Throughout COVID-19 Pandemic
October 12th 2021
Influenza Vaccination Timing and Reluctance
October 12th 2021
Pros and Cons of Available Influenza Vaccines
October 12th 2021
Identifying Patients at High Risk for Influenza Complications
October 12th 2021

Stephan Foster, PharmD, FAPhA, FNAP

Articles by Stephan Foster, PharmD, FAPhA, FNAP

Influenza Case 2: Male Patient With Chronic Health Conditions

Influenza Case 1: Female Patient With Asthma and Egg Allergy

Vaccination Misconceptions and Educating Patients

Influenza Vaccination Timing and Reluctance

Pros and Cons of Available Influenza Vaccines

Identifying Patients at High Risk for Influenza Complications

Addressing Influenza in the COVID-19 Era

Similarities and Differences in COVID-19 and Influenza

Feasibility of Concurrent COVID-19 and Influenza Vaccination

The Impact of Distancing, Masks, and Vaccination on Influenza

Evolving Influenza Trends Throughout COVID-19 Pandemic

Latest Updated Articles

Trending on Medical Economics

U.S. health care affordability hits a five-year low

Medicare’s 2027 Physician Fee Schedule: Will primary care finally be paid for what it actually does?

FDA clears BlueWind Medical's Revi Extend implant, extending device life to 15 years

Insurance was never meant to be a first-dollar payer, with Joanne Frederick

AI can reduce wasteful spending in Medicare — but WISeR isn't the answer